{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:31Z","timestamp":1772119531138,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the International Scientific Exchange Foundation of China","award":["Z2024LLN005"],"award-info":[{"award-number":["Z2024LLN005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-025-01766-z","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T02:46:33Z","timestamp":1766198793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High expression of formin-2 can promote ovarian cancer chemoresistance via immunosuppressive macrophages"],"prefix":"10.1007","volume":"26","author":[{"given":"Shuo","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"1766_CR1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0047","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, Alvarez RD, Backes FJ et al (2022) NCCN guidelines\u00ae insights: ovarian Cancer, version 3.2022. J Natl Compr Canc Netw. https:\/\/doi.org\/10.6004\/jnccn.2022.0047","journal-title":"J Natl Compr Canc Netw"},{"key":"1766_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nature13862","author":"L Bonapace","year":"2014","unstructured":"Bonapace L, Coissieux MM, Wyckoff J et al (2014) Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. https:\/\/doi.org\/10.1038\/nature13862","journal-title":"Nature"},{"key":"1766_CR3","doi-asserted-by":"publisher","first-page":"1250258","DOI":"10.3389\/fimmu.2023.1250258","volume":"14","author":"F Brauneck","year":"2023","unstructured":"Brauneck F, Oliveira-Ferrer L, Muschhammer J et al (2023) Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro. Front Immunol 14:1250258. https:\/\/doi.org\/10.3389\/fimmu.2023.1250258","journal-title":"Front Immunol"},{"issue":"24","key":"1766_CR4","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1158\/0008-5472.CAN-22-0455","volume":"82","author":"LM Chambers","year":"2022","unstructured":"Chambers LM, Rhoades ELE, Bharti R et al (2022) Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Cancer Res 82(24):4654\u20134669. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0455","journal-title":"Cancer Res"},{"issue":"6","key":"1766_CR5","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1182\/blood-2010-10-311001","volume":"117","author":"C Charfi","year":"2011","unstructured":"Charfi C, Voisin V, Levros LC et al (2011) Gene profiling of graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene. Blood 117(6):1899\u20131910. https:\/\/doi.org\/10.1182\/blood-2010-10-311001","journal-title":"Blood"},{"issue":"5\u20136","key":"1766_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00335-015-9568-9","volume":"26","author":"E Chaum","year":"2015","unstructured":"Chaum E, Winborn CS, Bhattacharya S (2015) Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium. Mamm Genome 26(5\u20136):210\u2013221. https:\/\/doi.org\/10.1007\/s00335-015-9568-9","journal-title":"Mamm Genome"},{"key":"1766_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-020-0120-3","author":"MY Chen","year":"2020","unstructured":"Chen MY, Zhang B, Topatana W et al (2020) Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning. NPJ Precis Oncol. https:\/\/doi.org\/10.1038\/s41698-020-0120-3","journal-title":"NPJ Precis Oncol"},{"issue":"12","key":"1766_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1515\/hsz-2013-0176","volume":"394","author":"S Dietrich","year":"2013","unstructured":"Dietrich S, Weiss S, Pleiser S et al (2013) Structural and functional insights into the Spir\/formin actin nucleator complex. Biol Chem 394(12):1649\u20131660. https:\/\/doi.org\/10.1515\/hsz-2013-0176","journal-title":"Biol Chem"},{"key":"1766_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07177-7","author":"J George","year":"2024","unstructured":"George J, Maas L, Abedpour N et al (2024) Evolutionary trajectories of small cell lung cancer under therapy. Nature. https:\/\/doi.org\/10.1038\/s41586-024-07177-7","journal-title":"Nature"},{"key":"1766_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3653","author":"N Gruel","year":"2014","unstructured":"Gruel N, Benhamo V, Bhalshankar J et al (2014) Polarity gene alterations in pure invasive micropapillary carcinomas of the breast. Breast Cancer Res. https:\/\/doi.org\/10.1186\/bcr3653","journal-title":"Breast Cancer Res"},{"key":"1766_CR11","doi-asserted-by":"publisher","unstructured":"Guan LY, Li Z, Xie FF et al (2020) Oncogenic and drug-sensitive mutations in human epithelial ovarian cancer. J Exp Clin Canc Res 39(1). https:\/\/doi.org\/10.1186\/s13046-020-01557-3","DOI":"10.1186\/s13046-020-01557-3"},{"key":"1766_CR12","doi-asserted-by":"publisher","first-page":"1427380","DOI":"10.3389\/fimmu.2024.1427380","volume":"15","author":"T Huang","year":"2024","unstructured":"Huang T, Ren X, Tang X et al (2024) Current perspectives and trends of CD39-CD73-eAdo\/A2aR research in tumor microenvironment: a bibliometric analysis. Front Immunol 15:1427380. https:\/\/doi.org\/10.3389\/fimmu.2024.1427380","journal-title":"Front Immunol"},{"key":"1766_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jgm.2898","volume":"19","author":"J Jin","year":"2017","unstructured":"Jin J, Wang Y, Xu Y et al (2017) MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2. J Gene Med 19:6\u20137. https:\/\/doi.org\/10.1002\/jgm.2898","journal-title":"J Gene Med"},{"key":"1766_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102554","author":"L Labat-de-Hoz","year":"2021","unstructured":"Labat-de-Hoz L, Alonso MA (2021) Formins in human disease. Cells. https:\/\/doi.org\/10.3390\/cells10102554","journal-title":"Cells"},{"issue":"44","key":"1766_CR15","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.3748\/wjg.v24.i44.5013","volume":"24","author":"DJ Li","year":"2018","unstructured":"Li DJ, Feng ZC, Li XR et al (2018) Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis. World J Gastroenterol 24(44):5013\u201324. https:\/\/doi.org\/10.3748\/wjg.v24.i44.5013","journal-title":"World J Gastroenterol"},{"key":"1766_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004029","author":"H Li","year":"2022","unstructured":"Li H, Luo F, Jiang XY et al (2022) CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-004029","journal-title":"J Immunother Cancer"},{"issue":"11","key":"1766_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.10.002","volume":"35","author":"J Li","year":"2023","unstructured":"Li J, Zheng CM, Mai QW et al (2023) Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer. Cell Metab 35(11):2044. https:\/\/doi.org\/10.1016\/j.cmet.2023.10.002","journal-title":"Cell Metab"},{"key":"1766_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10142-024-01295-1","volume":"24","author":"ZF Li","year":"2024","unstructured":"Li ZF, Liu JL, Wang P et al (2024) The novel miR-873-5p-YWHAE-PI3K\/AKT axis is involved in non-small cell lung cancer progression and chemoresistance by mediating autophagy. Funct Integr Genomics 24:33. https:\/\/doi.org\/10.1007\/s10142-024-01295-1","journal-title":"Funct Integr Genomics"},{"issue":"1","key":"1766_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/2326-6066.CIR-21-0407","volume":"10","author":"T Miyamoto","year":"2022","unstructured":"Miyamoto T, Murakami R, Hamanishi J et al (2022) B7-H3 suppresses antitumor immunity via the CCL2-CCR2-M2 macrophage axis and contributes to ovarian cancer progression. Cancer Immunol Res 10(1):56\u201369. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0407","journal-title":"Cancer Immunol Res"},{"issue":"26","key":"1766_CR22","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.ygyno.2023.11.034","volume":"187","author":"G Mollaoglu","year":"2024","unstructured":"Mollaoglu G, Tepper A, Falcomat\u00e0 C et al (2024) Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell 187(26):7492\u20137510e22. https:\/\/doi.org\/10.1016\/j.ygyno.2023.11.034","journal-title":"Cell"},{"issue":"1","key":"1766_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4314\/bcse.v39i1.11","volume":"39","author":"BR Nawghare","year":"2025","unstructured":"Nawghare BR, Joshi RR, Lokhande PD (2025) Chemoselective metal free deallylation of \u03b1-allyl-phenylcarboxylic esters under reduction condition. Bull Chem Soc Ethiop 39(1):131\u2013139. https:\/\/doi.org\/10.4314\/bcse.v39i1.11","journal-title":"Bull Chem Soc Ethiop"},{"key":"1766_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02088-1","author":"SP Nie","year":"2021","unstructured":"Nie SP, Zhang L, Liu JH et al (2021) ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-021-02088-1","journal-title":"J Exp Clin Cancer Res"},{"key":"1766_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03079-2","author":"BY Pan","year":"2023","unstructured":"Pan BY, Wan T, Zhou Y et al (2023) The MYBL2-CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-023-03079-2","journal-title":"Cancer Cell Int"},{"key":"1766_CR26","doi-asserted-by":"publisher","unstructured":"Raja A, Malik MFA, Haq F (2021) Genomic relevance of and associated genes on the prognosis of pancreatic cancer. PLoS ONE 16(6). https:\/\/doi.org\/10.1371\/journal.pone.0252344","DOI":"10.1371\/journal.pone.0252344"},{"issue":"1","key":"1766_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jmoldx.2019.08.006","volume":"22","author":"JL Sepulveda","year":"2020","unstructured":"Sepulveda JL (2020) Using R and bioconductor in clinical genomics and transcriptomics. J Mol Diagn 22(1):3\u201320. https:\/\/doi.org\/10.1016\/j.jmoldx.2019.08.006","journal-title":"J Mol Diagn"},{"issue":"1","key":"1766_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41389-022-00419-1","volume":"11","author":"Y Shen","year":"2022","unstructured":"Shen Y, Ren Y, Chen K et al (2022) The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma. Oncogenesis 11(1):43. https:\/\/doi.org\/10.1038\/s41389-022-00419-1","journal-title":"Oncogenesis"},{"issue":"6","key":"1766_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/23744235.2021.1892178","volume":"53","author":"Y Shiraishi","year":"2021","unstructured":"Shiraishi Y, Kryukov K, Tomomatsu K et al (2021) Diagnosis of pleural empyema\/parapneumonic effusion by next-generation sequencing. Infect Dis 53(6):450\u20139. https:\/\/doi.org\/10.1080\/23744235.2021.1892178","journal-title":"Infect Dis"},{"issue":"1","key":"1766_CR30","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41467-020-20140-0","volume":"11","author":"M Song","year":"2020","unstructured":"Song M, Yeku OO, Rafiq S et al (2020) Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun 11(1):6298. https:\/\/doi.org\/10.1038\/s41467-020-20140-0","journal-title":"Nat Commun"},{"issue":"8","key":"1766_CR31","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41388-019-1090-1","volume":"39","author":"CY Sun","year":"2020","unstructured":"Sun CY, Li X, Guo ES et al (2020) MCP-1\/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. Oncogene 39(8):1681\u201395. https:\/\/doi.org\/10.1038\/s41388-019-1090-1","journal-title":"Oncogene"},{"issue":"3","key":"1766_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"1766_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262000","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhao SJ, Qin QH et al (2022) CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0262000","journal-title":"PLoS One"},{"issue":"1","key":"1766_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Zhu X et al (2024) Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer 23(1):66. https:\/\/doi.org\/10.1186\/s12943-024-01967-3","journal-title":"Mol Cancer"},{"issue":"5","key":"1766_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ (2024) Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol 21(5):389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3","journal-title":"Nat Rev Clin Oncol"},{"key":"1766_CR36","doi-asserted-by":"publisher","first-page":"1543096","DOI":"10.3389\/fimmu.2025.1543096","volume":"16","author":"C Xu","year":"2025","unstructured":"Xu C, Chen J, Tan M et al (2025) The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials. Front Immunol 16:1543096. https:\/\/doi.org\/10.3389\/fimmu.2025.1543096","journal-title":"Front Immunol"},{"issue":"15","key":"1766_CR37","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.4161\/cc.25511","volume":"12","author":"K Yamada","year":"2013","unstructured":"Yamada K, Ono M, Bensaddek D et al (2013) FMN2 is a novel regulator of the cyclin-dependent kinase inhibitor p21. Cell Cycle 12(15):2348\u20132354. https:\/\/doi.org\/10.4161\/cc.25511","journal-title":"Cell Cycle"},{"issue":"1","key":"1766_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang H, Zhang Q, Xu M et al (2020) CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer 19(1):41. https:\/\/doi.org\/10.1186\/s12943-020-01165-x","journal-title":"Mol Cancer"},{"issue":"7","key":"1766_CR39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y et al (2023) The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol 20(7):714\u2013738. https:\/\/doi.org\/10.1038\/s41423-023-01013-0","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"1766_CR40","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1007\/s12010-023-04456-3","volume":"195","author":"Q Yu","year":"2023","unstructured":"Yu Q, Zhang Y, Tian Y et al (2023) Exosomal circ_FMN2 derived from the serum of colorectal cancer patients promotes cancer progression by miR-338-3p\/MSI1 axis. Appl Biochem Biotechnol 195(12):7322\u20137337. https:\/\/doi.org\/10.1007\/s12010-023-04456-3","journal-title":"Appl Biochem Biotechnol"},{"issue":"12","key":"1766_CR41","doi-asserted-by":"publisher","first-page":"300060521106624","DOI":"10.1177\/03000605211066245","volume":"49","author":"T Zhang","year":"2021","unstructured":"Zhang T, Liu Q, Zhu Y et al (2021) Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer. J Int Med Res 49(12):3000605211066245. https:\/\/doi.org\/10.1177\/03000605211066245","journal-title":"J Int Med Res"},{"key":"1766_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1030198","author":"XQ Zhang","year":"2023","unstructured":"Zhang XQ, Chao P, Zhang L et al (2023) Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1030198","journal-title":"Front Immunol"},{"key":"1766_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-023-01075-3","volume":"23","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Li X, Yang BK et al (2023) SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer. Funct Integr Genomics 23:147. https:\/\/doi.org\/10.1007\/s10142-023-01075-3","journal-title":"Funct Integr Genomics"},{"key":"1766_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08108-9","author":"Y Zhuang","year":"2021","unstructured":"Zhuang Y, Wang HL, Jiang D et al (2021) Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-021-08108-9","journal-title":"BMC Cancer"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01766-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01766-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01766-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T02:46:34Z","timestamp":1766198794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01766-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01766-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7209240\/v1","asserted-by":"object"}]},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee at the Third Affiliated Hospital of Zhengzhou University approved all the experimental protocols in the present study (approval no. 2023\u2009\u2212\u2009120).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}